Reduction and complete discontinuation should not be treated as the same stated goal.
Among 183 survey participants, about 59% were willing to reduce and 43% to stop benzodiazepine-receptor agonists if advised by their doctor. Satisfaction with treatment, perceived low risk, fear of stopping and limited support were reported barriers.
Stated willingness does not establish that medication was subsequently changed. Cross-sectional associations cannot determine whether changing beliefs would cause cessation. The category included related hypnotics as well as benzodiazepines.
Preserve the distinction between patient goals, attempted change and confirmed outcome. The findings cannot justify assuming an individual refuses all risk reduction merely because complete cessation is unwanted. Review the person’s stated concerns, actual treatment plan and follow-up rather than substituting a survey profile for informed discussion.
Source: PMC12676567, supplied full-text paper. Findings are paraphrased; forensic implications are an interpretation.
Related: Dantrolene in Severe GHB Withdrawal Addressed More Than Failure to Sedate.